Success Stories

Event Videos

Fatty liver disease in children (MAFLD/PeFLD Type 2): unique classification considerations and challenges https://pubmed.ncbi.nlm.nih.gov/36968656/ NAFLD Ther Adv Endocrinol Metab. 2023 Mar 22;14:20420188231160388. doi: 10.1177/20420188231160388. eCollection 2023. Fatty liver disease in children (MAFLD/PeFLD Type 2): unique classification considerations and challenges Robert Hegarty 1, Eirini Kyrana 1, Emer Fitzpatrick 2, Anil Dhawan 3 Abstract Published on: Mar-2023 Read more	Intestinal failure-associated liver disease and growth pre- and post-transition to a composition lipid emulsion https://pubmed.ncbi.nlm.nih.gov/36930972/ J Pediatr Gastroenterol Nutr. 2023 Mar 17. doi: 10.1097/MPG.0000000000003763.Online ahead of print. Intestinal failure-associated liver disease and growth pre- and post-transition to a composition lipid emulsion Alexandra S Hudson 1 2, Nicole Tyminski 2, Justine M Turner 1 2, Jason A Silverman 1 2 Abstract Objectives: Infants with intestinal failure have an increased risk of intestinal failure-associated liver disease (IFALD). Composite intravenous lipid emulsion (ILE) may reduce the risk of cholestasis. The primary outcome was to compare IFALD rates in infants with intestinal failure, between those receiving a composite ILE versus soybean oil ILE. The secondary outcome compared growth between these two groups. Published on: Mar-2023 Read more
Predictors of biliary atresia outcome: Saudi National Study (2000 - 2018) https://pubmed.ncbi.nlm.nih.gov/36960526/ biliary atresia Saudi J Gastroenterol. 2023 Mar 20. doi: 10.4103/sjg.sjg_512_22. Online ahead of print. Predictors of biliary atresia outcome: Saudi National Study (2000 - 2018) Mohammed Abanemai 1, Mohammed AlEdreesi 2, Ahmed Al Sarkhy 3, Omar I Saadah 4, Homoud Alhebbi 5, Razan Bader 6, Maher Alhatlani 7, Hana Halabi 8, Ahmed Aladsani 9, Sami Wali 5, Talal Alguofi 10, Fahad Alsayed 1, Amira NasserAllah 11, Ahmed Almehmadi 8, Afnan Qurban 8, Muhammed Salman Bashir 12, Aisha Alamri 13, Abdulrahman Al-Hussaini 14 Abstract Published on: Mar-2023 Read more	Aetiology and outcome of adult and paediatric acute liver failure in Europe https://pubmed.ncbi.nlm.nih.gov/36930963/ Acute liver failure J Pediatr Gastroenterol Nutr. 2023 Mar 17. doi: 10.1097/MPG.0000000000003777.Online ahead of print. Aetiology and outcome of adult and paediatric acute liver failure in Europe Dominic Lenz 1 2, Marianne Hørby Jørgensen 2 3, Deirdre Kelly 2 4, Vincenzo Cardinale 2 5, Anja Geerts 2 6, Isabel Gonçalves Costa 2 7, Alexander Fichtner 1 2, Sven F Garbade 1 2, Bianca Hegen 2 8, Johannes Hilberath 2 9, Ruben de Kleine 2 10, Limas Kupčinskas 2 11, Valérie McLin 2 12, Moritz Niesert 1 2, Veronica Prado Gonzalez 2 13, Ekkehard Sturm 2 9, Christian Staufner 1 2, Eric Tjwa 2 14, José Willemse 2 15, Britta F Zecher 2 16, Fin Stolze Larsen 2 17, Marcial Sebode 2 16, Henriette Ytting 2 18 Abstract Published on: Mar-2023 Read more
Fluid balance in pediatric postoperative liver transplant recipients https://pubmed.ncbi.nlm.nih.gov/36951112/ Transplant Pediatr Transplant. 2023 Mar 23;e14499. doi: 10.1111/petr.14499. Online ahead of print. Fluid balance in pediatric postoperative liver transplant recipients Jessica M Winters 1, Rebecca Brocks 2, Catherine A Chapin 3, Caroline P Lemoine 4, Riccardo Superina 4, Katherine A Brandt 4, L Nelson Sanchez-Pinto 5, Matthew F Barhight 5 Abstract Background: Positive fluid balance (FB) is associated with poor outcomes in critically ill children but has not been studied in pediatric liver transplant (LT) recipients. Our goal is to investigate the relationship between postoperative FB and outcomes in pediatric LT recipients. Published on: Mar-2023 Read more	"Daily vitamin D supplementation improves vitamin D deficiency in patients with chronic liver disease" https://pubmed.ncbi.nlm.nih.gov/36917843/ Chronic liver disease J Pediatr Gastroenterol Nutr. 2023 Mar 15. doi: 10.1097/MPG.0000000000003769.Online ahead of print. "Daily vitamin D supplementation improves vitamin D deficiency in patients with chronic liver disease" Carolina Roos Mariano da Rocha 1, Guilherme Guaragna Filho 2 3, Carlos Oscar Kieling 4, Marina Rossato Adami 4, Renata Rostirola Guedes 4, Sandra Maria Gonçalves Vieira 1 3 4 Abstract Objective: To evaluate the response to 6,000 IU oral cholecalciferol (OC) treatment in children with chronic liver disease (CLD) and 25(OH)D deficiency. Published on: Mar-2023 Read more
Expression of miR-let7b and miR-19b in Progressive familial intrahepatic cholestasis (PFIC) children https://pubmed.ncbi.nlm.nih.gov/36934840/ PFIC Gastroenterol Hepato. 2023 Mar 17;S0210-5705(23)00064-X. doi: 10.1016/j.gastrohep.2023.03.001. Online ahead of print. Expression of miR-let7b and miR-19b in Progressive familial intrahepatic cholestasis (PFIC) children [Article in English, Spanish] Mahintaj Dara 1, Negar Azarpira 2, Nasrin Motazedian 3, Mahdokht Hossein-Aghdaie 3, Seyed-Mohsen Dehghani 3, Bita Geramizadeh 4, Elaheh Esfandiari 3 Abstract Published on: Mar-2023 Read more	Liver disease in GLIS 3 mutations - Transplant considerations and bile duct paucity on explant histology https://pubmed.ncbi.nlm.nih.gov/36917836/ J Pediatr Gastroenterol Nutr. 2023 Mar 15. doi: 10.1097/MPG.0000000000003773.Online ahead of print. Liver disease in GLIS 3 mutations - Transplant considerations and bile duct paucity on explant histology Michael R Couper 1, Rachel M Brown 2, Girish Gupte 1, M Thamara P R Perera 1, Chayarani Kelgeri 1 Abstract Published on: Mar-2023 Read more
The Effectiveness and Safety of Antibody Induction Immunosuppression in a Large Cohort of U.S. Pediatric Liver Transplant Recipients https://pubmed.ncbi.nlm.nih.gov/36933831/ Transplant Am J Transplant. 2023 Mar 16;S1600-6135(23)00351-9. doi: 10.1016/j.ajt.2023.03.008.Online ahead of print. The Effectiveness and Safety of Antibody Induction Immunosuppression in a Large Cohort of U.S. Pediatric Liver Transplant Recipients Phoebe Wood 1, Yuan-Shung Huang 2, Lucia Sanchez 3, Eimear Kitt 4, Peter L Abt 5, Therese Bittermann 6 Abstract Published on: Mar-2023 Read more	Severe Acute Hepatitis: An Emerging Grave Illness in Children https://pubmed.ncbi.nlm.nih.gov/36916359/ Acute hepatitis Indian Pediatr. 2023 Mar 15;60(3):181-182. Severe Acute Hepatitis: An Emerging Grave Illness in Children Raghvendra Singh 1, Akshay Kapoor 2 Affiliations expand Abstract Acute hepatitis of unknown origin in children has been recently described in the literature, and a case definition has also been proposed for this condition. The exact etiology is unknown and exclusion of infectious, metabolic, autoimmune and toxin mediated injuries is essential. Management for this condition is supportive, but some may require liver transplantation. Infection prevention and control practices are important as the etiology remains unidentified. Published on: Mar-2023

CLF Intro movie

SMS requests to

9224791366

Ask The Expert

Pediatric Liver Specialists in India

Centres offering Genetic Testing for Pediatric Liver Diseases

Financial Aid Offered by Trusts

Follow us on:

Facebook Twitter YouTube